MediciNova Stock Forecast

Stock Price Forecast

The 4 analysts that cover MediciNova stock have a consensus rating of "Strong Buy" and an average price target of $7.50, which forecasts a 431.91% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $10.

Price Target: $7.50 (+431.91%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$7.50	$9.00	$10
Change	+254.61%	+431.91%	+538.30%	+609.22%

* Price targets were last updated on Mar 23, 2026.

Analyst Ratings

The average analyst rating for MediciNova stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	2	2	2	4	4
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Initiates $6	Strong Buy	Initiates	$6	+325.53%	Mar 23, 2026
Lander Egaña Gorroño HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $10	Strong Buy	Initiates	$10	+609.22%	Mar 16, 2026
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $9	Strong Buy	Maintains	$9	+538.30%	Jan 30, 2026
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $9	Strong Buy	Maintains	$9	+538.30%	Dec 18, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $9	Strong Buy	Maintains	$9	+538.30%	Dec 8, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

127.50K

from 409.66K

-68.88%

from 409.66K

Revenue Next Year

357.00K

from 127.50K

180.00%

from 127.50K

EPS This Year

-0.31

from -0.24

EPS Next Year

-0.41

from -0.31

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	4.04M	-	1.00M	-	409.66K	127.50K	357.00K
Revenue Growth	-	-	-	-	-	-68.88%	180.00%
EPS	-0.21	-0.29	-0.17	-0.23	-0.24	-0.31	-0.41
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	525,000	735,000
Avg	127,500	357,000
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	28.2%	476.5%
Avg	-68.9%	180.0%
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.27	-0.39
Avg	-0.31	-0.41
Low	-0.37	-0.42

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.